首页> 外文期刊>The journal of clinical psychiatry >Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
【24h】

Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial

机译:卢拉西酮治疗具有混合性(亚综合征性低血压)特征的双相抑郁症:随机安慰剂对照试验的事后分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Mixed (subsyndromal hypomanic) features are prevalent in patients with bipolar depression and are associated with more severe and complex illness, including increased risk for suicide attempts, higher switch to mania during antidepressant therapy, and a higher rate of recurrence. The aim of this post hoc analysis was to evaluate the efficacy and safety of lurasidone in the treatment of patients with bipolar depression presenting with mixed features.
机译:目的:躁郁症患者普遍存在混合(亚综合征性躁狂)特征,并伴有更严重,更复杂的疾病,包括自杀未遂风险增加,抗抑郁治疗期间转向躁狂症的风险增加以及复发率更高。这项事后分析的目的是评估卢拉西酮在治疗具有混合特征的双相抑郁症患者中的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号